Dr. Richard Vile

7 advances in CAR-T cell therapy at Mayo Clinic

Read about the research being conducted to improve CAR-T cell therapy and expand its capabilities to treat more conditions.

Unleashing viruses aimed at killing cancer

Richard Vile, Ph.D., is leading research into genetically engineered viruses called oncolytic viruses for cancer treatment at Mayo Clinic.

Mayo Clinic researchers load CAR-T cells with oncolytic virus to treat solid cancer tumors

Researchers used a new immunotherapy technique that combines chimeric antigen receptor-T cell therapy, or CAR-T cell therapy, with a cancer-killing virus to more effectively target and treat solid cancer tumors in mouse models.